Kidney International Supplements
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 8.3 | Q1 | 94.0% | 12.369 | Q1 | 99.8% |
| 2024 | 89.6 | Q1 | 100.0% | 10.788 | Q1 | 99.8% |
| 2023 | 19.3 | Q1 | 98.4% | 3.126 | Q1 | 98.0% |
| 2022 | 5.5 | Q1 | 91.2% | 1.333 | Q1 | 91.5% |
| 2021 | 6.1 | Q1 | 89.9% | 2.680 | Q1 | 97.6% |
| 2020 | — | — | 2.855 | Q1 | 97.7% | |
| 2019 | — | — | 1.792 | Q1 | 94.6% | |
| 2018 | — | — | 1.730 | Q1 | 93.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2157-1724
ISSN
2157-1716
country
UScoverage
2011-2022, 2024-2025